Clinical Trial

Xanthohumol Metabolism and Signature

Study acronym: XMaS
Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
A pilot study to assess the safety and tolerability of oral xanthohumol in humans, to identify a biological signature of xanthohumol exposure, and to characterize the role of xanthohumol metabolism by intestinal microorganisms in that signature.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2018-11-06; most recent amendment 2024-08-02.
Status change: Recruiting → Active, Not Recruiting 2020-08-25
Status change: Not Yet Recruiting → Recruiting 2019-08-27
Trial Details
NCT Number NCT03735420
Lead Sponsor National University of Natural Medicine
Collaborators: Oregon State University, Pacific Northwest National Laboratory
Conditions Healthy
Enrollment 30 participants
Start Date 2019-08-12
Primary Completion 2020-05-07 (estimated)
Study Completion 2024-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-27